Integration of the cancer-related pro-inflammatory response as a stratifying biomarker of survival benefit with sorafenib in hepatocellular carcinoma

File(s)

SorafenibPaper_v6_FINAL.docx (142.59 KB)

Accepted version

Show more

Author(s)

Howell, J

Pinato, D

Ramaswami, R

Arizumi, T

Ferrari, C

more

Type

Journal Article

Date Issued

2016-09-22

Date Acceptance

2016-04-16

Citation

Journal of Hepatology, 2016, 64 (2), pp.S195-S195

URI

http://hdl.handle.net/10044/1/42904

DOI

https://www.dx.doi.org/10.1016/S0168-8278(16)01705-0

ISSN

1600-0641

Publisher

Elsevier

Start Page

S195

End Page

S195

Journal / Book Title

Journal of Hepatology

Volume

64

Issue

2

Copyright Statement

© 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Gastroenterology & Hepatology

1103 Clinical Sciences

Publication Status

Published